OpenVSafe by OpenVAERS
Search V-safe

7GK-14235-69462

3 vaccinations 4 coded responses 37 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
452 / OH
Registered
2021-03-19
Relationship
Self
Race
Other
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-19
    Registered in v-safe
  3. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  8. 2021-03-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-01
    Survey response — day 14, dose 1
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activities
    Free text: I have developed enlarged and painful lymph nodes in the axillary tail of my breast and some in the supraclavicular area.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-08
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-08
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  12. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  13. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-15
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  19. 2021-04-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-06
    Survey response — day 28, dose 2
    MedDRA: Blister, Dysphonia, Eye pruritus, Headache, Hypersensitivity, Oropharyngeal pain, Pre-existing disease, Rhinorrhoea, Self-medication, Sneezing, Urticaria — Feeling: Fair
    Free text: Unusually hypersensitive to outdoor allergens and bug bites resulting in very large welts, blisters, itchy eyes, sore throat, hoarseness, sneezing, headache, runny nose despite taking usual claritin and were much better with advil and benedryl.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-20
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-07-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-10-07
    Survey response — 6 months, dose 2
    MedDRA: Vertigo — Feeling: Good · Be unable to do your normal daily activities
    Free text: I experienced vertigo for about 3 days. It resolved without any evaluation or treatment.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-12
    Dose 3 — Pfizer-BioNTech
  27. 2021-10-12
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  28. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  29. 2021-10-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Diarrhea
    Adult check-in
  31. 2021-10-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache · Be unable to do your normal daily activities
    Adult check-in
  33. 2021-10-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-19
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-26
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-02
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-09
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-23
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-01-11
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-04-14
    Survey response — 6 months, dose 3
    MedDRA: COVID-19, Conjunctivitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Covid with conjunctivitis that last 4-5 weeks.
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-04-14
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  43. 2022-04-20
  44. 2022-04-20
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-18Pfizer-BioNTech
22021-04-08Pfizer-BioNTech
32021-10-12Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 6 — day 14, dose 1

2021-04-01

Symptoms: I have developed enlarged and painful lymph nodes in the axillary tail of my breast and some in the supraclavicular area.

Release 8 — day 28, dose 2

2021-05-06

Symptoms: Unusually hypersensitive to outdoor allergens and bug bites resulting in very large welts, blisters, itchy eyes, sore throat, hoarseness, sneezing, headache, runny nose despite taking usual claritin and were much better with advil and benedryl.

Release 10 — 6 months, dose 2

2021-10-07

Symptoms: I experienced vertigo for about 3 days. It resolved without any evaluation or treatment.

Release 11 — 6 months, dose 3

2022-04-14

Symptoms: Covid with conjunctivitis that last 4-5 weeks.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlister ✓ ✓ ✓
SDConjunctivitis · · ✓
SDCOVID-19 · · ✓
SDDysphonia ✓ ✓ ✓
SDEye pruritus ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDLymph node pain ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SDSelf-medication ✓ ✓ ✓
SDSneezing ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓
SDVertigo · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release